Header Logo

Connection

Yahya Choonara to Antiparkinson Agents

This is a "connection" page, showing publications Yahya Choonara has written about Antiparkinson Agents.
Connection Strength

0,496
  1. Targeted Delivery of Amantadine-loaded Methacrylate Nanosphere-ligands for the Potential Treatment of Amyotrophic Lateral Sclerosis. J Pharm Pharm Sci. 2018; 21(1):94-109.
    View in: PubMed
    Score: 0,149
  2. Design of an interpolyelectrolyte gastroretentive matrix for the site-specific zero-order delivery of levodopa in Parkinson's disease. AAPS PharmSciTech. 2013 Jun; 14(2):605-19.
    View in: PubMed
    Score: 0,107
  3. Levodopa delivery systems: advancements in delivery of the gold standard. Expert Opin Drug Deliv. 2010 Feb; 7(2):203-24.
    View in: PubMed
    Score: 0,086
  4. Design, biometric simulation and optimization of a nano-enabled scaffold device for enhanced delivery of dopamine to the brain. Int J Pharm. 2009 Dec 01; 382(1-2):277-90.
    View in: PubMed
    Score: 0,084
  5. Advances in the treatment of Parkinson's disease. Prog Neurobiol. 2007 Jan; 81(1):29-44.
    View in: PubMed
    Score: 0,070
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.